Pluripotent stem cells: patent pooling and HESC comparisons

9 February 2011

Considered a potentially more ethically acceptable alternative to human embryonic stem (HES) cells, iPS cells are the subject of intensive research efforts. A new method for comparing them with ‘gold standard’ HES cells based on genomic profiles has just reported a high level of equivalence, though some researchers are less confident that iPS cells will perform as well. 

More from us

Genomics and policy news